SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Cell Origin Biotech (Hangzhou) Co., Ltd.
University of Kentucky
Hamilton Health Sciences Corporation
The Hospital for Sick Children
Hospital del Mar
The Hospital for Sick Children
Chang Gung Memorial Hospital
Ludwig-Maximilians - University of Munich
Silesian Centre for Heart Diseases
Rigshospitalet, Denmark
Soonchunhyang University Hospital
Henry Ford Health System
Istanbul University - Cerrahpasa
Drexel University
Selcuk University
Canada Royal Enoch Phytomedicine Co., Ltd.
Selcuk University
Xidian University
National Taiwan University Hospital
Karadeniz Technical University
Gynaecologisch Oncologisch Centrum Zuid
CHA University
Sixth Affiliated Hospital, Sun Yat-sen University
University of Roma La Sapienza
Northwestern University
Northwestern University
Centre Hospitalier de Perigueux
Lady Davis Institute
Ruijin Hospital
M.D. Anderson Cancer Center
University of California, San Francisco
Ludwig-Maximilians - University of Munich
Grand River Hospital
Shenzhen Fifth People's Hospital
The Hospital for Sick Children
Laval University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Merck Sharp & Dohme LLC
Chinese PLA General Hospital
University of Aarhus
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Tufts Medical Center
Seoul National University Hospital